[3rd and 4th generation estroprogestatives French controversy: What effect on women's behavior?]

Area of Science:

• Reproductive Health
• Pharmaceutical Sciences
• Sociology of Health

Background:

• The 2013 French controversy surrounding third and fourth-generation estroprogestatives (EP) raised concerns about vascular risks.
• Media debates and public discourse significantly influenced women's perceptions and decisions regarding contraceptive methods.

Purpose of the Study:

• To investigate the reasons women cited for changing or suspending their contraceptive methods in 2013.
• To assess the influence of the estroprogestative (EP) controversy and medical advice on these decisions.
• To explore the impact of the controversy on women's lifestyles and interactions with healthcare professionals.

Main Methods:

• An anonymous, self-administered questionnaire was distributed to 988 women aged 18-55.
• Participants were categorized into 'exposed' (heard of the controversy) and 'unexposed' groups.
• Key parameters compared included changes in contraceptive methods and decisions made with or against medical advice.

Main Results:

• 38.5% of women changed their contraception in 2013; 40.1% of those aware of the controversy did so against medical advice.
• Contraceptive method changes were linked to lifestyle shifts in 52.1% of women who stopped contraception entirely.
• The EP controversy was a primary reason for change in 41.8% of cases, while doctor's advice played a role in only 19.9%.

Conclusions:

• The estroprogestative (EP) controversy was a leading factor for women altering or discontinuing contraception.
• Media influence appeared to supersede medical recommendations, potentially affecting the doctor-patient relationship.
• While medical reasons were cited, the controversy's impact on decision-making and trust in healthcare professionals warrants attention.